WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF CONTENTS Page 3 4 6 2]
WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF
[WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF CONTENTS Page 3 4 6 2]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF CONTENTS Page 3 Preliminary Scheme Document (as filed with the Grand Court of the Cayman Islands and subject to its approval at a hearing scheduled for June 29, 2010) 4 2 WuXi PharmaTech (Cayman) Inc. S E I / Ge Li Chairman and Chief Executive Officer 3 www.sec.gov This preliminary Scheme Document]
WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF
[WuXi PharmaTech (Cayman) Inc. Form 6-K TABLE OF CONTENTS Page 3 Preliminary Scheme Document (as filed with the Grand Court of the Cayman Islands and subject to its approval at a hearing scheduled for June 29, 2010) 4 2 WuXi PharmaTech (Cayman) Inc. S E I / Ge Li Chairman and Chief Executive Officer 3 www.sec.gov This preliminary Scheme Document]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4 2]
WX [WuXi PharmaTech (Cayman)] SC 13G/A: (Original Filing)
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 60,226,056 Item 6: 0 Item 7: 64,626,784 Item 8: 0 Item 9: 64,626,784 Item 11: 11.656% Item 12: HC Cusip #929352920 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 64,626,784 Item 8: 0 Item 9: 64,626,784 Item 11: 11.656%]
